Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bayer warns physicians about Trasylol

Bayer (FSE:BAY; BAY) issued a warning to healthcare professionals on Thursday after the Canadian BART trial was stopped because of higher mortality in

Read the full 234 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE